抗凝固剤逆転薬の世界市場 (2025～2029年)

抗凝固剤逆転薬市場 (2025～2029年)

抗凝固剤逆転薬市場は2024年から2029年に12億7,000万米ドル分拡大し、予測期間中に12.5%のCAGRで成長すると予測されます。当レポートでは、抗凝固剤逆転薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25社のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。この市場は、凝固障害の有病率の増加、股関節および膝関節手術の増加、ベンダー間の戦略的合併・買収などが牽引しています。

当レポートでは、今後数年間の抗凝固剤逆転薬市場の成長を牽引する主な要因の一つとして、新興国への注目度の上昇を挙げています。また、研究開発活動や新たな治療用途の増加、医療専門家の関心増大が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 Technavioによる分析

• 価格感応度・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
• インプットの重要性と差別化の要因
• 混乱の要因
• 促進要因と課題の影響

第3章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第4章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 (2024年)
• 市場の見通し (2024～2029年)

第5章 市場規模実績

• 世界の抗凝固剤逆転薬市場 (2019～2023年)
• 流通チャネル別分析 (2019～2023年)
• 地域別分析 (2019～2023年)
• 国別分析 (2019～2023年)

第6章 定性分析

• AIの影響：世界の抗凝固剤逆転薬市場

第7章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第8章 市場区分：流通チャネル別

• 市場区分
• 比較：流通チャネル別
• 病院薬局：市場規模と予測 (2024～2029年)
• 小売薬局：市場規模と予測 (2024～2029年)
• オンライン薬局：市場規模と予測 (2024～2029年)
• 市場機会：流通チャネル別

第9章 顧客情勢

• 顧客情勢の概要

第10章 地域別情勢

• 地域別区分
• 地域別比較
• 北米：市場規模と予測 (2024～2029年)
• 欧州：市場規模と予測 (2024～2029年)
• アジア：市場規模と予測 (2024～2029年)
• 世界のその他の地域：市場規模と予測 (2024～2029年)
• 米国：市場規模と予測 (2024～2029年)
• ドイツ：市場規模と予測 (2024～2029年)
• カナダ：市場規模と予測 (2024～2029年)
• 中国：市場規模と予測 (2024～2029年)
• 英国：市場規模と予測 (2024～2029年)
• フランス：市場規模と予測 (2024～2029年)
• 日本：市場規模と予測 (2024～2029年)
• イタリア：市場規模と予測 (2024～2029年)
• 韓国：市場規模と予測 (2024～2029年)
• インド：市場規模と予測 (2024～2029年)
• 市場機会：地域別

第11章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第12章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第13章 競合分析

• 企業プロファイル
• 企業ランキング指数
• 企業の市場ポジショニング
• Amboss GmbH
• Amneal Pharmaceuticals Inc.
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Boehringer Ingelheim International GmbH
• Covis Pharma GmbH
• CSL Ltd.
• GoodRx Holdings Inc.
• Midas Pharma GmbH
• Pfizer Inc.

第14章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Company Market Positioning
• Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits10: Overview on criticality of inputs and factors of differentiation
• Exhibits11: Overview on factors of disruption
• Exhibits12: Impact of drivers and challenges in 2024 and 2029
• Exhibits13: Parent Market
• Exhibits14: Data Table on - Parent Market
• Exhibits15: Market characteristics analysis
• Exhibits16: Value chain analysis
• Exhibits17: Offerings of companies included in the market definition
• Exhibits18: Market segments
• Exhibits19: Chart on Global - Market size and forecast 2024-2029 ($ million)
• Exhibits20: Data Table on Global - Market size and forecast 2024-2029 ($ million)
• Exhibits21: Chart on Global Market: Year-over-year growth 2024-2029 (%)
• Exhibits22: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
• Exhibits23: Historic Market Size - Data Table on Global Anticoagulant Reversal Drugs Market 2019 - 2023 ($ million)
• Exhibits24: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
• Exhibits25: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• Exhibits26: Historic Market Size - Country Segment 2019 - 2023 ($ million)
• Exhibits27: Five forces analysis - Comparison between 2024 and 2029
• Exhibits28: Bargaining power of buyers - Impact of key factors 2024 and 2029
• Exhibits29: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• Exhibits30: Threat of new entrants - Impact of key factors in 2024 and 2029
• Exhibits31: Threat of substitutes - Impact of key factors in 2024 and 2029
• Exhibits32: Threat of rivalry - Impact of key factors in 2024 and 2029
• Exhibits33: Chart on Market condition - Five forces 2024 and 2029
• Exhibits34: Chart on Distribution Channel - Market share 2024-2029 (%)
• Exhibits35: Data Table on Distribution Channel - Market share 2024-2029 (%)
• Exhibits36: Chart on Comparison by Distribution Channel
• Exhibits37: Data Table on Comparison by Distribution Channel
• Exhibits38: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
• Exhibits39: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
• Exhibits40: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
• Exhibits41: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
• Exhibits42: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
• Exhibits43: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
• Exhibits44: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
• Exhibits45: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
• Exhibits46: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
• Exhibits47: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
• Exhibits48: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
• Exhibits49: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
• Exhibits50: Market opportunity by Distribution Channel ($ million)
• Exhibits51: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits53: Chart on Market share By Geographical Landscape 2024-2029 (%)
• Exhibits54: Data Table on Market share By Geographical Landscape 2024-2029 (%)
• Exhibits55: Chart on Geographic comparison
• Exhibits56: Data Table on Geographic comparison
• Exhibits57: Chart on North America - Market size and forecast 2024-2029 ($ million)
• Exhibits58: Data Table on North America - Market size and forecast 2024-2029 ($ million)
• Exhibits59: Chart on North America - Year-over-year growth 2024-2029 (%)
• Exhibits60: Data Table on North America - Year-over-year growth 2024-2029 (%)
• Exhibits61: Chart on Europe - Market size and forecast 2024-2029 ($ million)
• Exhibits62: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
• Exhibits63: Chart on Europe - Year-over-year growth 2024-2029 (%)
• Exhibits64: Data Table on Europe - Year-over-year growth 2024-2029 (%)
• Exhibits65: Chart on Asia - Market size and forecast 2024-2029 ($ million)
• Exhibits66: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
• Exhibits67: Chart on Asia - Year-over-year growth 2024-2029 (%)
• Exhibits68: Data Table on Asia - Year-over-year growth 2024-2029 (%)
• Exhibits69: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
• Exhibits70: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
• Exhibits71: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• Exhibits72: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• Exhibits73: Chart on US - Market size and forecast 2024-2029 ($ million)
• Exhibits74: Data Table on US - Market size and forecast 2024-2029 ($ million)
• Exhibits75: Chart on US - Year-over-year growth 2024-2029 (%)
• Exhibits76: Data Table on US - Year-over-year growth 2024-2029 (%)
• Exhibits77: Chart on Germany - Market size and forecast 2024-2029 ($ million)
• Exhibits78: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
• Exhibits79: Chart on Germany - Year-over-year growth 2024-2029 (%)
• Exhibits80: Data Table on Germany - Year-over-year growth 2024-2029 (%)
• Exhibits81: Chart on Canada - Market size and forecast 2024-2029 ($ million)
• Exhibits82: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
• Exhibits83: Chart on Canada - Year-over-year growth 2024-2029 (%)
• Exhibits84: Data Table on Canada - Year-over-year growth 2024-2029 (%)
• Exhibits85: Chart on China - Market size and forecast 2024-2029 ($ million)
• Exhibits86: Data Table on China - Market size and forecast 2024-2029 ($ million)
• Exhibits87: Chart on China - Year-over-year growth 2024-2029 (%)
• Exhibits88: Data Table on China - Year-over-year growth 2024-2029 (%)
• Exhibits89: Chart on UK - Market size and forecast 2024-2029 ($ million)
• Exhibits90: Data Table on UK - Market size and forecast 2024-2029 ($ million)
• Exhibits91: Chart on UK - Year-over-year growth 2024-2029 (%)
• Exhibits92: Data Table on UK - Year-over-year growth 2024-2029 (%)
• Exhibits93: Chart on France - Market size and forecast 2024-2029 ($ million)
• Exhibits94: Data Table on France - Market size and forecast 2024-2029 ($ million)
• Exhibits95: Chart on France - Year-over-year growth 2024-2029 (%)
• Exhibits96: Data Table on France - Year-over-year growth 2024-2029 (%)
• Exhibits97: Chart on Japan - Market size and forecast 2024-2029 ($ million)
• Exhibits98: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
• Exhibits99: Chart on Japan - Year-over-year growth 2024-2029 (%)
• Exhibits100: Data Table on Japan - Year-over-year growth 2024-2029 (%)
• Exhibits101: Chart on Italy - Market size and forecast 2024-2029 ($ million)
• Exhibits102: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
• Exhibits103: Chart on Italy - Year-over-year growth 2024-2029 (%)
• Exhibits104: Data Table on Italy - Year-over-year growth 2024-2029 (%)
• Exhibits105: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
• Exhibits106: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
• Exhibits107: Chart on South Korea - Year-over-year growth 2024-2029 (%)
• Exhibits108: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• Exhibits109: Chart on India - Market size and forecast 2024-2029 ($ million)
• Exhibits110: Data Table on India - Market size and forecast 2024-2029 ($ million)
• Exhibits111: Chart on India - Year-over-year growth 2024-2029 (%)
• Exhibits112: Data Table on India - Year-over-year growth 2024-2029 (%)
• Exhibits113: Market opportunity By Geographical Landscape ($ million)
• Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits115: Impact of drivers and challenges in 2024 and 2029
• Exhibits116: Overview on criticality of inputs and factors of differentiation
• Exhibits117: Overview on factors of disruption
• Exhibits118: Impact of key risks on business
• Exhibits119: Companies covered
• Exhibits120: Company ranking index
• Exhibits121: Matrix on companies position and classification
• Exhibits122: Amboss GmbH - Overview
• Exhibits123: Amboss GmbH - Product / Service
• Exhibits124: Amboss GmbH - Key offerings
• Exhibits125: SWOT
• Exhibits126: Amneal Pharmaceuticals Inc. - Overview
• Exhibits127: Amneal Pharmaceuticals Inc. - Business segments
• Exhibits128: Amneal Pharmaceuticals Inc. - Key news
• Exhibits129: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibits130: Amneal Pharmaceuticals Inc. - Segment focus
• Exhibits131: SWOT
• Exhibits132: AstraZeneca Plc - Overview
• Exhibits133: AstraZeneca Plc - Product / Service
• Exhibits134: AstraZeneca Plc - Key news
• Exhibits135: AstraZeneca Plc - Key offerings
• Exhibits136: SWOT
• Exhibits137: Bausch Health Companies Inc. - Overview
• Exhibits138: Bausch Health Companies Inc. - Business segments
• Exhibits139: Bausch Health Companies Inc. - Key news
• Exhibits140: Bausch Health Companies Inc. - Key offerings
• Exhibits141: Bausch Health Companies Inc. - Segment focus
• Exhibits142: SWOT
• Exhibits143: Boehringer Ingelheim International GmbH - Overview
• Exhibits144: Boehringer Ingelheim International GmbH - Product / Service
• Exhibits145: Boehringer Ingelheim International GmbH - Key news
• Exhibits146: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits147: SWOT
• Exhibits148: Covis Pharma GmbH - Overview
• Exhibits149: Covis Pharma GmbH - Product / Service
• Exhibits150: Covis Pharma GmbH - Key offerings
• Exhibits151: SWOT
• Exhibits152: CSL Ltd. - Overview
• Exhibits153: CSL Ltd. - Business segments
• Exhibits154: CSL Ltd. - Key news
• Exhibits155: CSL Ltd. - Key offerings
• Exhibits156: CSL Ltd. - Segment focus
• Exhibits157: SWOT
• Exhibits158: GoodRx Holdings Inc. - Overview
• Exhibits159: GoodRx Holdings Inc. - Product / Service
• Exhibits160: GoodRx Holdings Inc. - Key offerings
• Exhibits161: SWOT
• Exhibits162: Midas Pharma GmbH - Overview
• Exhibits163: Midas Pharma GmbH - Product / Service
• Exhibits164: Midas Pharma GmbH - Key offerings
• Exhibits165: SWOT
• Exhibits166: Pfizer Inc. - Overview
• Exhibits167: Pfizer Inc. - Product / Service
• Exhibits168: Pfizer Inc. - Key news
• Exhibits169: Pfizer Inc. - Key offerings
• Exhibits170: SWOT
• Exhibits171: Inclusions checklist
• Exhibits172: Exclusions checklist
• Exhibits173: Currency conversion rates for US$
• Exhibits174: Research methodology
• Exhibits175: Information sources
• Exhibits176: Data validation
• Exhibits177: Validation techniques employed for market sizing
• Exhibits178: Data synthesis
• Exhibits179: 360 degree market analysis
• Exhibits180: List of abbreviations

Anticoagulant Reversal Drugs Market 2025-2029

The anticoagulant reversal drugs market is forecasted to grow by USD 1270 mn during 2024-2029, accelerating at a CAGR of 12.5% during the forecast period. The report on the anticoagulant reversal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of coagulation disorders, increase in hip and knee surgeries, and strategic mergers and acquisitions among vendors.

Technavio's anticoagulant reversal drugs market is segmented as below:

By Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing focus on emerging economies as one of the prime reasons driving the anticoagulant reversal drugs market growth during the next few years. Also, increasing research and development activities and new therapeutic applications and rising awareness among healthcare professionals will lead to sizable demand in the market.

The report on the anticoagulant reversal drugs market covers the following areas:

• Anticoagulant Reversal Drugs Market sizing
• Anticoagulant Reversal Drugs Market forecast
• Anticoagulant Reversal Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anticoagulant reversal drugs market vendors that include Amboss GmbH, Amneal Pharmaceuticals Inc., AstraZeneca Plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Covis Pharma GmbH, CSL Ltd., GoodRx Holdings Inc., Midas Pharma GmbH, and Pfizer Inc.. Also, the anticoagulant reversal drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Anticoagulant Reversal Drugs Market 2019 - 2023
  • Historic Market Size - Data Table on Global Anticoagulant Reversal Drugs Market 2019 - 2023 ($ million)
• 5.2 Distribution Channel segment analysis 2019 - 2023
  • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
• 5.3 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.4 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on the Global Anticoagulant Reversal Drugs Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

• 8.1 Market segments
  • Chart on Distribution Channel - Market share 2024-2029 (%)
  • Data Table on Distribution Channel - Market share 2024-2029 (%)
• 8.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 8.3 Hospital pharmacy - Market size and forecast 2024-2029
  • Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
• 8.4 Retail pharmacy - Market size and forecast 2024-2029
  • Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
• 8.5 Online pharmacy - Market size and forecast 2024-2029
  • Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
• 8.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

9 Customer Landscape

• 9.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 10.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 10.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 10.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 10.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 10.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 10.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 10.8 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 10.9 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 10.10 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 10.11 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 10.12 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 10.13 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 10.14 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 10.15 South Korea - Market size and forecast 2024-2029
  • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• 10.16 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 10.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

11 Drivers, Challenges, and Opportunity/Restraints

• 11.1 Market drivers
• 11.2 Market challenges
• 11.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 11.4 Market opportunities/restraints

12 Competitive Landscape

• 12.1 Overview
• 12.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 12.3 Landscape disruption
  • Overview on factors of disruption
• 12.4 Industry risks
  • Impact of key risks on business

13 Competitive Analysis

• 13.1 Companies profiled
  • Companies covered
• 13.2 Company ranking index
  • Company ranking index
• 13.3 Market positioning of companies
  • Matrix on companies position and classification
• 13.4 Amboss GmbH
  • Amboss GmbH - Overview
  • Amboss GmbH - Product / Service
  • Amboss GmbH - Key offerings
  • SWOT
• 13.5 Amneal Pharmaceuticals Inc.
  • Amneal Pharmaceuticals Inc. - Overview
  • Amneal Pharmaceuticals Inc. - Business segments
  • Amneal Pharmaceuticals Inc. - Key news
  • Amneal Pharmaceuticals Inc. - Key offerings
  • Amneal Pharmaceuticals Inc. - Segment focus
  • SWOT
• 13.6 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 13.7 Bausch Health Companies Inc.
  • Bausch Health Companies Inc. - Overview
  • Bausch Health Companies Inc. - Business segments
  • Bausch Health Companies Inc. - Key news
  • Bausch Health Companies Inc. - Key offerings
  • Bausch Health Companies Inc. - Segment focus
  • SWOT
• 13.8 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
  • SWOT
• 13.9 Covis Pharma GmbH
  • Covis Pharma GmbH - Overview
  • Covis Pharma GmbH - Product / Service
  • Covis Pharma GmbH - Key offerings
  • SWOT
• 13.10 CSL Ltd.
  • CSL Ltd. - Overview
  • CSL Ltd. - Business segments
  • CSL Ltd. - Key news
  • CSL Ltd. - Key offerings
  • CSL Ltd. - Segment focus
  • SWOT
• 13.11 GoodRx Holdings Inc.
  • GoodRx Holdings Inc. - Overview
  • GoodRx Holdings Inc. - Product / Service
  • GoodRx Holdings Inc. - Key offerings
  • SWOT
• 13.12 Midas Pharma GmbH
  • Midas Pharma GmbH - Overview
  • Midas Pharma GmbH - Product / Service
  • Midas Pharma GmbH - Key offerings
  • SWOT
• 13.13 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT

14 Appendix

• 14.1 Scope of the report
• 14.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 14.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 14.4 Research methodology
  • Research methodology
• 14.5 Data procurement
  • Information sources
• 14.6 Data validation
  • Data validation
• 14.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 14.8 Data synthesis
  • Data synthesis
• 14.9 360 degree market analysis
  • 360 degree market analysis
• 14.10 List of abbreviations
  • List of abbreviations